Market Research

RNA Interference Market to Grow at a CAGR of 16.5% During Forecast Period 2020-2025

Jul 16, 2020 8:00 PM ET

iCrowd Newswire – Jul 16, 2020

RNA Interference Market size was $9.44Bn in 2019, growing at a CAGR of 16.5% during the forecast period 2020-2025. RNA Interference is a conserved biological process to double-stranded RNA that mediates resistance to endogenous parasitic and exogenous pathogenic nucleic acids and regulates protein coding genes. It is used in studying gene functions as it allows sequence specific gene suppression in eukaryotic organisms and cultured cells. It is a mechanism of silencing gene expression after the gene has been transcribed owing to the presence of anti-sense RNA and targets mRNA. It is process of treating forms of cancer and other diseases by post-transcriptional silencing of genes (Caenorhabditis elegans) by small fragments of the nucleic acid.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=502175

Report Price: $ 4500 (Single User License)  

By Drug Delivery Type – Segment Analysis

In 2019, Nano Particle Drug Deliverysegment dominated the RNA Interference Market in terms of revenue is estimated to grow at a CAGR of 11.4%. It is used for the treatment of cardiovascular diseases, cancer, and others by passing the nano particles into the genes. The nano particles are wangled to get attracted towards the diseased cells for the direct treatment of cancerous cells. Drug delivery devices offer direct delivery to the site of therapy, improving treatment outcomes while reducing side effects and overall associated healthcare costs abetting towards the market’s growth.

Geography – Segment Analysis

In 2019, the North America region dominated RNA Interference Market in terms of revenue with a market share of 36%owing towards the increase ofRNA Interference. This growth can be attributed towards the increasing cases of oncology, cardiology, genetic disorders and others in this region. Government has taken initiatives to promote technological advancements in this region are key factors in the growth of the RNA Interference market.Asia Pacific is estimated to record the fastest growth rate during the forecast period 2020-2025.

Talk to one of our sales representative about the full report by providing your details in the link below:

https://www.industryarc.com/support.php?id=502175

Drivers – RNA Interference Market

  • Increase In The Improvement of RNA Delivery

Increase of safety regulations by the Government for food industries drive the RNA Interference Market. Increase in the genetic and metabolic disorders including diseases like cancer, cardiology and increasing applications in molecular diagnostics is driving the market’s growth.The aptamer drug delivery is the second most used type offering several advantages compared to protein and small-molecule drugs, such as low risk of side-effects and complications in humans and enhanced their drug like properties including improved stability and residence time in the bloodstream is the other major factor driving growth of the RNA Interference market.

Challenges – RNA Interference Market

  • Government Regulations

The lack of proficient organization for RNA Interference system and growing stringent government policy and regulation toward market growth is restraining growth of the market.Increase of safety regulations by the Government for healthcare industries drive the RNA Interference Market. Government rules on RNAiare immunogenic and inherently unstable, which causes major problems for the research and development of drugs are restraining the growth of the market.

Acquisitions/Product Launches

  • In October 2019,Thermo Fisher Scientific Inc.launched Cell Culture Media. It provides a flexible alternative for biological researchers that also save energyto enable our customers to make the world healthier, cleaner and safer.
  • In January 2020, Merck & Co. Inc. acquired Zedi’s ArQule, Inc. This acquisition helped the company inincreasing the production.

Key Takeaways

  • Increased research in the field of RNA therapeutics is set to propel the growth of the market.
  • Increasing genetic and metabolic disorders including diseases like cancer and Cardiology worldwide drives the market’s growth.
  • Europe region is estimated to record the fastest growth rate during the forecast period 2020-2025.

RNA Interference Industry Outlook

Product Launches was the key strategy of the players in the RNA Interference Industry. RNA Interference top 10companiesincludeMerck & Co. Inc., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Tacere Therapeutics Inc., PhaseRx Inc., Sirnaomics Inc., Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Phio Pharmaceuticals Corporation and Thermo Fisher Scientific Inc.

Related Reports:

Ribonucleic Acid Interference (RNAi) Technology Market

https://www.industryarc.com/Report/16232/ribonucleic-acid-interference-rnai-technology-market.html

Time of Flight Camera Market 

https://www.industryarc.com/Report/16970/time-of-flight-camera-market.html

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Contact Information:

Venkat Reddy
Sales Director
Email: [email protected]
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677


iCrowdNewswire

Keywords:    RNA Interference market, RNA Interference market size, RNA Interference industry, RNA Interference market share, RNA Interference top 10 companies, RNA Interference market report, RNA Interference industry outlook